ARTICLE | Clinical News
Dyloject diclofenac sodium: Preliminary Phase II/III data
July 18, 2005 7:00 AM UTC
Innovative Drug Delivery Systems Inc., New York, N.Y. Product: Dyloject diclofenac sodium Business: Neurology Molecular target: Cyclooxygenases (COX) Description: Non-steroidal anti-inflammatory dru...